Among patients who did not receive anti-IL-6 receptor monoclonal antibodies, there was an increased unadjusted risk of progression of respiratory failure or death among males compared to female patients; although this did not quite reach statistical significance ( p = 0.058).
← all excerpts
Biological sex is associated with heterogeneous responses to IL-6 receptor inhibitor treatment in COVID-19-A retrospective cohort study.
2
0.0580
0.0660
The sentences
There was an increased unadjusted risk of progression of respiratory failure or death among females compared to male patients; although this did not reach statistical significance ( p = 0.066) (Fig. 2 b).